Ivermectin is a medication primarily used to treat parasitic infections [1]. When formulated with a binder, it suggests a solid dosage form, such as a tablet or capsule [2]. Binders are inactive ingredients used in pharmaceutical manufacturing to hold the active drug and other excipients together, ensuring the tablet's integrity and proper dissolution [2].
Why might Ivermectin need a binder?
A binder is essential for creating stable, cohesive tablets. Without it, powders would not stick together, making the production of solid dosage forms impossible [2]. Binders help in the granulation process, which improves the flow properties of the powder mixture, leading to uniform tablet weight and content uniformity [2].
What other ingredients might be in an Ivermectin tablet?
Besides the active ingredient ivermectin and a binder, pharmaceutical formulations typically include other inactive ingredients called excipients. These can include fillers (to add bulk), disintegrants (to help the tablet break apart in the body), lubricants (to prevent sticking during manufacturing), and glidants (to improve powder flow) [2]. The specific combination of excipients is chosen to ensure the drug is stable, bioavailable, and easy to manufacture [2].
Where can I find information on Ivermectin drug patents?
Information regarding drug patents, including those for formulations or specific uses of ivermectin, can be found through resources like DrugPatentWatch.com [3]. This site tracks patent filings and expiration dates, which are crucial for understanding market exclusivity and the potential for generic competition [3].